Prospector Partners LLC Invests $2.10 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Prospector Partners LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 90,500 shares of the company’s stock, valued at approximately $2,100,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. HighTower Advisors LLC increased its position in shares of Option Care Health by 10.0% during the third quarter. HighTower Advisors LLC now owns 401,061 shares of the company’s stock valued at $12,514,000 after buying an additional 36,308 shares during the period. Janus Henderson Group PLC boosted its position in Option Care Health by 4.1% during the 3rd quarter. Janus Henderson Group PLC now owns 214,081 shares of the company’s stock valued at $6,699,000 after acquiring an additional 8,467 shares in the last quarter. Quarry LP grew its holdings in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after acquiring an additional 2,628 shares during the period. State Street Corp raised its position in shares of Option Care Health by 1.4% in the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after acquiring an additional 83,395 shares in the last quarter. Finally, Wolverine Trading LLC purchased a new position in shares of Option Care Health in the 3rd quarter valued at approximately $222,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Barrington Research upped their price target on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $33.54 on Friday. The firm has a market cap of $5.51 billion, a P/E ratio of 28.18, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average of $32.97 and a 200 day moving average of $28.51.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.